Using Cluster Analysis to Investigate Consumption Patterns in Cases Positive to Ketamine: a National 7-year Study

Overview

Journal Naunyn Schmiedebergs Arch Pharmacol

Specialty Pharmacology

Date 2025 Mar 14

PMID 40085215

Authors

Shyh-Yuh Wei

Chien-Chou Su

Hsuan-Yun Hu

Chih-Hsin Pan

Affiliations

Soon will be listed here.

Abstract

The use of ketamine has increased; however, actual consumption patterns and ketamine-related deaths remain poorly understood. This study aimed to (1) cluster the consumption patterns of individuals who consume ketamine and (2) investigate their associations with manner and cause of death. A retrospective study was conducted on all cases positive to ketamine at death, retrieved from the Institute of Forensic Medicine between 2013 and 2019. A total of 414 individuals tested positive for ketamine in various samples, including blood, pleural effusion, hair, and others, with 294 individuals having detectable ketamine in their blood samples, which were subsequently clustered. The most prevalent patterns identified were ketamine plus alcohol (49.5%), ketamine plus new psychoactive substances (39.1%), and ketamine plus methamphetamine (24.4%). Drug intoxication was the most reported cause of death, followed by traffic accidents. Cluster 1 exhibited moderate ketamine concentrations (1.7 µg/mL), a high prevalence of polydrug use (85%), and an increased risk of suicide. Cluster 4 displayed very low ketamine concentrations (0.13 µg/mL) but similarly high rates of polydrug use (85%) and an elevated risk of accidental death. The concurrent use of ketamine and alcohol, primarily categorized within cluster 3, accounted for nearly half of the deaths resulting from drug intoxication or traffic accidents. Our study underscores the potential dangers of using ketamine as one of multiple substances. Our study also emphasized the critical role that consumption patterns and dosages play in determining the potential lethal outcomes associated with ketamine. In the future, medical applications of ketamine must consider patients' use of other substances and inform them of the associated risks.

References

Chen L, Chen C, Chen C, Chang H, Huang M, Xu K . Association of Craving and Depressive Symptoms in Ketamine-Dependent Patients Undergoing Withdrawal Treatment. Am J Addict. 2019; 29(1):43-50. DOI: 10.1111/ajad.12978. View

Chen W, Chen C, Wu S, Wu K, Jou S, Tung Y . The impact of Taiwan's implementation of a nationwide harm reduction program in 2006 on the use of various illicit drugs: trend analysis of first-time offenders from 2001 to 2017. Harm Reduct J. 2021; 18(1):117. PMC: 8603590. DOI: 10.1186/s12954-021-00566-5. View

Dakwar E, Levin F, Hart C, Basaraba C, Choi J, Pavlicova M . A Single Ketamine Infusion Combined With Motivational Enhancement Therapy for Alcohol Use Disorder: A Randomized Midazolam-Controlled Pilot Trial. Am J Psychiatry. 2019; 177(2):125-133. DOI: 10.1176/appi.ajp.2019.19070684. View

Darke S, Duflou J, Farrell M, Peacock A, Lappin J . Characteristics and circumstances of death related to the self-administration of ketamine. Addiction. 2020; 116(2):339-345. DOI: 10.1111/add.15154. View

Garel N, Tate S, Nash K, Lembke A . Trends in hallucinogen-associated emergency department visits and hospitalizations in California, USA, from 2016 to 2022. Addiction. 2024; 119(5):960-964. DOI: 10.1111/add.16432. View

Grabski M, McAndrew A, Lawn W, Marsh B, Raymen L, Stevens T . Adjunctive Ketamine With Relapse Prevention-Based Psychological Therapy in the Treatment of Alcohol Use Disorder. Am J Psychiatry. 2022; 179(2):152-162. DOI: 10.1176/appi.ajp.2021.21030277. View

Kalsi S, Wood D, Dargan P . The epidemiology and patterns of acute and chronic toxicity associated with recreational ketamine use. Emerg Health Threats J. 2013; 4:7107. PMC: 3168228. DOI: 10.3402/ehtj.v4i0.7107. View

Kaye S, HAAG H . Terminal blood alcohol concentrations in ninety-four fatal cases of acute alcoholism. J Am Med Assoc. 1957; 165(5):451-2. DOI: 10.1001/jama.1957.72980230001006. View

Kwan A, Rosenblat J, Mansur R, Rhee T, Teopiz K, Le G . A replication study using the World Health Organization pharmacovigilance database (VigiBase®) to evaluate whether an association between ketamine and esketamine and alcohol and substance misuse exists. J Affect Disord. 2024; 363:589-594. DOI: 10.1016/j.jad.2024.07.128. View

10.

Kwan A, Rosenblat J, Mansur R, Teopiz K, McIntyre R . The association between ketamine and esketamine with alcohol and substance misuse: Reports to the Food and Drug Administration adverse event reporting system (FAERS). J Affect Disord. 2024; 360:421-426. DOI: 10.1016/j.jad.2024.05.116. View

11.

Leung J, Mekonen T, Wang X, Arunogiri S, Degenhardt L, McKetin R . Methamphetamine exposure and depression-A systematic review and meta-analysis. Drug Alcohol Rev. 2023; 42(6):1438-1449. DOI: 10.1111/dar.13670. View

12.

Liang H, Lau C, Tang A, Chan F, Ungvari G, Tang W . Cognitive impairments in poly-drug ketamine users. Addict Behav. 2013; 38(11):2661-6. DOI: 10.1016/j.addbeh.2013.06.017. View

13.

Liu H, Liu R, Ho H, Lin D . Development of an information-rich LC-MS/MS database for the analysis of drugs in postmortem specimens. Anal Chem. 2009; 81(21):9002-11. DOI: 10.1021/ac901599d. View

14.

Liu H, Yang C, Liu R, Lin D . Developing a UHPLC-QTOF-MS and Automated Library Search Method for Screening Drugs and Toxic Compounds in Postmortem Specimens. J Anal Toxicol. 2017; 41(5):421-430. DOI: 10.1093/jat/bkx026. View

15.

Moghaddam B, Krystal J . Capturing the angel in "angel dust": twenty years of translational neuroscience studies of NMDA receptor antagonists in animals and humans. Schizophr Bull. 2012; 38(5):942-9. PMC: 3446228. DOI: 10.1093/schbul/sbs075. View

16.

Morgan C, Muetzelfeldt L, Curran H . Ketamine use, cognition and psychological wellbeing: a comparison of frequent, infrequent and ex-users with polydrug and non-using controls. Addiction. 2009; 104(1):77-87. DOI: 10.1111/j.1360-0443.2008.02394.x. View

17.

Wei Y, Zhao J, Wong I, Wan E, Taylor D, Blais J . Relation of substance use disorders to mortality, accident and emergency department attendances, and hospital admissions: A 13-year population-based cohort study in Hong Kong. Drug Alcohol Depend. 2021; 229(Pt B):109119. DOI: 10.1016/j.drugalcdep.2021.109119. View

18.

Winstock A, Mitcheson L, Gillatt D, Cottrell A . The prevalence and natural history of urinary symptoms among recreational ketamine users. BJU Int. 2012; 110(11):1762-6. DOI: 10.1111/j.1464-410X.2012.11028.x. View

19.

Wu S, Chen L, Hsiao P, Ting T, Yen C, Chang S . The Use of Premixed Drugs in Commodity Packets in the Population: Prevalence and Correlates Revealed by the 2018 National Survey of Substance Use in Taiwan. J Epidemiol. 2023; 34(5):218-227. PMC: 10999518. DOI: 10.2188/jea.JE20220356. View

20.

Yang C, Liu H, Lin D, Liu R, Hsieh Y, Wu S . Simultaneous Quantitation of Methamphetamine, Ketamine, Opiates and their Metabolites in Urine by SPE and LC-MS-MS. J Anal Toxicol. 2017; 41(8):679-687. DOI: 10.1093/jat/bkx057. View